Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000258959 is classified as a pseudogene, specifically named "Novel pseudogene, ortholog of 1700001K19Rik (M. musculus)." Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they arise due to gene duplication or retrotransposition events and have acquired mutations that prevent them from producing functional proteins. This pseudogene does not encode a protein or act as a known therapeutic target such as a receptor, enzyme, or transporter. Its biological relevance, molecular mechanisms, and roles in disease are currently unknown, and there are no known drugs or biomarkers associated with it[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel pseudogene, ortholog of 1700001K19Rik.